Patents by Inventor Ouriel Faktor

Ouriel Faktor has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230079291
    Abstract: The present invention provides a method, wherein the method classifies a subject as suffering from dry eye, the method consisting of: a. obtaining demographic data, consisting of the age and gender of the subject; b. obtaining a tear sample from the patient, and determining the level of human serum albumin; c. from the determined level of human serum albumin, assigning a score for the determined amount of human serum albumin; and d. from the assigned score, calculating a cutoff probability score, according to the following equation: exp ? ( - 0.6491 - 1.1142 * Albumin ) 1 + exp ? ( - 0.6491 - 1.1142 * Albumin ) wherein the subject has dry eye, if the calculated cutoff probability score is from 50% to 60%.
    Type: Application
    Filed: November 11, 2022
    Publication date: March 16, 2023
    Inventors: Amos SOMMER, Ouriel FAKTOR, Eran EILAT
  • Publication number: 20230076248
    Abstract: Provided herein are methods and kits for characterizing and for identifying autism and autism spectrum disorders.
    Type: Application
    Filed: February 1, 2021
    Publication date: March 9, 2023
    Inventors: Beni GESUNDHEIT, Philip David ZISMAN, Ronald ELLIS, Ouriel FAKTOR
  • Patent number: 11499980
    Abstract: The present invention provides a method, wherein the method classifies a subject as suffering from dry eye, the method consisting of: a. obtaining demographic data, consisting of the age and gender of the subject; b. obtaining a tear sample from the patient, and determining the level of human serum albumin; c. from the determined level of human serum albumin, assigning a score for the determined amount of human serum albumin; and d. from the assigned score, calculating a cutoff probability score, according to the following equation: exp ( - 0.6491 - 1.1142 * Albumin ) 1 + exp ( - 0.6491 - 1.1142 * Albumin ) wherein the subject has dry eye, if the calculated cutoff probability score is from 50% to 60%.
    Type: Grant
    Filed: January 3, 2020
    Date of Patent: November 15, 2022
    Assignee: Diagnostear, Ltd.
    Inventors: Amos Sommer, Ouriel Faktor, Eran Eilat
  • Publication number: 20200141945
    Abstract: The present invention provides a method, wherein the method classifies a subject as suffering from dry eye, the method consisting of: a. obtaining demographic data, consisting of the age and gender of the subject; b. obtaining a tear sample from the patient, and determining the level of human serum albumin; c. from the determined level of human serum albumin, assigning a score for the determined amount of human serum albumin; and d. from the assigned score, calculating a cutoff probability score, according to the following equation: exp ( - 0.6491 - 1.1142 * Albumin ) 1 + exp ( - 0.6491 - 1.1142 * Albumin ) wherein the subject has dry eye, if the calculated cutoff probability score is from 50% to 60%.
    Type: Application
    Filed: January 3, 2020
    Publication date: May 7, 2020
    Inventors: Amos Sommer, Ouriel Faktor, Eran Eilat
  • Patent number: 10527628
    Abstract: The present invention provides a method, wherein the method classifies a subject as suffering from dry eye, the method consisting of: a. obtaining demographic data, consisting of the age and gender of the subject; b. obtaining a tear sample from the patient, and determining the level of human serum albumin; c. from the determined level of human serum albumin, assigning a score for the determined amount of human serum albumin; and d. from the assigned score, calculating a cutoff probability score, according to the following equation: wherein the subject has dry eye, if the calculated cutoff probability score is from 50% to 60%. exp ? ( - 0.6491 - 1.1142 * Albumin ) 1 + exp ? ( - 0.6491 - 1.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: January 7, 2020
    Assignee: Diagnostear, Ltd.
    Inventors: Amos Sommer, Ouriel Faktor, Eran Eilat
  • Publication number: 20190360061
    Abstract: Methods and kits for identifying a subject having pre-cancerous advanced polyps or colorectal cancer based on the expression profile(s) of specific mRNA biomarkers. Methods and kits for diagnosing, preventing, managing therapy, monitoring and identifying predisposition to colorectal cancer.
    Type: Application
    Filed: August 13, 2019
    Publication date: November 28, 2019
    Inventors: Dana COHEN, Vardit MOSHAYOFF, Ouriel FAKTOR
  • Publication number: 20190302028
    Abstract: In one embodiment, the present invention is a method for diagnosing Dry Eye Syndrome by quantifying an amount of at least two markers in a tear sample collected from a subject, wherein the at least two markers are selected from the group consisting of: Human Serum Albumin (HSA), mucin, lactoferrin, and lysozyme. In some embodiments, the method is a multi-assay test.
    Type: Application
    Filed: January 13, 2017
    Publication date: October 3, 2019
    Inventors: Amos Sommera, Ouriel Faktor, Eran Eilat
  • Patent number: 10407737
    Abstract: Methods and kits for identifying a subject having pre-cancerous advanced polyps or colorectal cancer based on the expression profile(s) of specific mRNA biomarkers. Methods and kits for diagnosing, preventing, managing therapy, monitoring and identifying predisposition to colorectal cancer.
    Type: Grant
    Filed: April 2, 2015
    Date of Patent: September 10, 2019
    Assignee: BIO-MARCARE TECHNOLOGIES LTD.
    Inventors: Dana Cohen, Vardit Moshayoff, Ouriel Faktor
  • Publication number: 20190212342
    Abstract: The present invention provides a method, wherein the method classifies a subject as suffering from dry eye, the method consisting of: a. obtaining demographic data, consisting of the age and gender of the subject; b. obtaining a tear sample from the patient, and determining the level of human serum albumin; c. from the determined level of human serum albumin, assigning a score for the determined amount of human serum albumin; and d. from the assigned score, calculating a cutoff probability score, according to the following equation: wherein the subject has dry eye, if the calculated cutoff probability score is from 50% to 60%. exp ? ( - 0.6491 - 1.1142 * Albumin ) 1 + exp ? ( - 0.6491 - 1.
    Type: Application
    Filed: May 2, 2016
    Publication date: July 11, 2019
    Inventors: Amos Sommer, Ouriel Faktor, Eran Eilat
  • Publication number: 20170058357
    Abstract: Methods and kits for identifying a subject having pre-cancerous advanced polyps or colorectal cancer based on the expression profile(s) of specific mRNA biomarkers. Methods and kits for diagnosing, preventing, managing therapy, monitoring and identifying predisposition to colorectal cancer.
    Type: Application
    Filed: April 2, 2015
    Publication date: March 2, 2017
    Inventors: Dana COHEN, Vardit MOSHAYOFF, Ouriel FAKTOR
  • Publication number: 20050109951
    Abstract: A device, system and method for portable fluorescence detection. The portable device of the present invention features a low power light, in which a wavelength range is defined as at least one wavelength of light. The light source is preferably highly energy efficient, such that a majority of the electrical power which is consumed is then converted into transmitted light. The emitted light from the excited fluorophore is then preferably detected with any low cost and low power photodetector. Although optionally a highly sensitive optical detector may be used, preferably fluorescence is detected with any light sensing device, such as a regular photodiode or a CCD (charge-coupled device) sensor for example.
    Type: Application
    Filed: December 26, 2002
    Publication date: May 26, 2005
    Inventors: Falk Fish, Zvi Greenberg, Ouriel Faktor